Mentari Therapeutics: Funding, Investors & Team (Sep 2026)
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
Mentari Therapeutics has raised $200M across 1 funding round on record, the most recent a Private Equity of $200M announced in Jul 2026.
That round is above the $7.5M median round size for United States companies tracked on FundedIQ over the last two years.
Mentari Therapeutics Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Mentari Therapeutics Funding Rounds
Mentari Therapeutics Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Mentari Therapeutics Funding in Context
Mentari Therapeutics' latest round of $200M is above the median round in United States. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mentari Therapeutics in Biotechnology and Waltham
Companies Similar to Mentari Therapeutics
NovaGo Therapeutics is a Swiss biotech company developing human antibody therapeutics to promote regeneration…
Boulevard Bio is a biotechnology company founded by Deerfield Management that develops novel therapies for…
Syngenis Labs is committed to helping businesses and research organizations with their diagnostic and…
Botanical AI Pharmaceutical Company
Noise is a marketplace platform that develops and distributes branded content via social media, allowing…
Antfly is an AI-powered retrieval platform that enables intelligent search and data discovery for AI…
Universal Edge Technologies provides immersion-cooled, high-density modular edge data center platforms and…
ThoughtForm is a provider of strategy and design consultancy services.
Fever is the leading global live-entertainment discovery platform, helping millions of people every month to…
Magentic is a platform powered by artificial intelligence that detects cost savings within supply chains in…
Comp AI helps companies automate security compliance work and prepare for audits.
Phinge® Creating Netverse®, Patented App-less, Integrated Technologies & Verifed Platform & AI With…
Mentari Therapeutics Funding FAQs
What does Mentari Therapeutics do?
Mentari Therapeutics is a biotechnology company developing therapies for the prevention of migraine.
How much funding has Mentari Therapeutics raised?
Mentari Therapeutics has raised $200M across 1 round on record. The most recent is a Private Equity of $200M announced in Jul 2026.
When did Mentari Therapeutics last raise funding?
Mentari Therapeutics' most recent funding round on record is a Private Equity of $200M, announced in Jul 2026.
Who has invested in Mentari Therapeutics?
Investors on record for Mentari Therapeutics include Janus Henderson Investors, RTW Investments, Commodore Capital, Vivo Capital, Fairmount Funds Management. FundedIQ records 11 investors in total.
Where is Mentari Therapeutics headquartered?
Mentari Therapeutics is based in Waltham, United States.
About FundedIQ's Mentari Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mentari Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.